Newamsterdam Pharma Co NV

-

Stock Issuer and Owners

Home | Sign Up | Log In
Message
Happy Holidays!! thanks for using AUM13F!!
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Newamsterdam Pharma Co NV
TickerNAMSW
CIK #0001936258
CUSIPN62509117
SectorLife Sciences - Pharmaceutical Preparations
AddressGooimeer 2-35, Narrden, 1411 DC
Source [EDGAR]
CIK Filing 2011 - 2025
[0001936258] 10-K
[0001936258] 10-Q
[0001936258] 3
[0001936258] 4
[0001936258] 6-K
[0001936258] 8-K
[0001936258] SC 13D
[0001936258] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Capital World Investors Newamsterdam Pharma Co NV [2025-05-13] 0.0
Forbion Capital Fund IV Cooperatief UA Newamsterdam Pharma Co NV [2023-07-07] 8.1
Viking Global Investors LP Newamsterdam Pharma Co NV [2023-06-20] 7.98
BCLS II Investco LP Newamsterdam Pharma Co NV [2022-12-02] 4.9
Morningside Venture Investments Ltd Newamsterdam Pharma Co NV [2022-12-02] 6.21
Frazier Lifesciences Sponsor LLC Newamsterdam Pharma Co NV [2022-12-02] 4.9
Amgen Inc Newamsterdam Pharma Co NV [2022-12-02] 9.0
RA Capital Management LP Newamsterdam Pharma Co NV [2022-12-02] 5.29
Form 3/4/5 Filer 2011 - 2025
Topper James N
NewAmsterdam Pharma Co N.V.
Kling Douglas F
Lange Louis G
Marino Michael F III
Audet Juliette Berangere
Gulfo Adele M.
Davidson Michael H.
Kastelein Johannes Jacob Pieter
Kooij Louise Frederika
Somaiya Mayur Ian
van der Kamp Hilde Johanna
Smither John W
McKenna Mark C.
Lewis William
Jones William A Jr
Forbion Growth Management B.V.
Forbion Growth Opportunities Fund I Cooperatief U.A.
ForGrowth NAP B.V.
Forbion IV Management B.V.
Forbion Capital Fund IV Cooperatief U.A.
BCLS II Investco (GP), LLC
BCIP Life Sciences Associates, LP
Bain Capital Life Sciences Investors, LLC
Bain Capital Life Sciences Fund III, L.P.
BCLS II Investco, LP
Bain Capital Life Sciences Fund II, L.P.
BCLS Fund III Investments GP, LLC
Bain Capital Life Sciences III General Partner, LLC
Bain Capital Life Sciences Investors II, LLC
BCLS Fund III Investments, LP
Joustra Wouter
Downing Nicholas
Slootweg Hugo Alexander
Form 13F Holdings
Firm Period DFND Voting Shares
Frazier Life Sciences Management LP [2025-06-30] SOLE 500,333 500,333
RA Capital Management LP [2025-06-30] SOLE 333,333 333,333
Affinity Asset Advisors LLC [2025-06-30] SOLE 245,000 245,000
Bain Capital Life Sciences Investors, LLC [2025-06-30] SOLE 100,000 100,000
Deerfield Management Company LP [2025-06-30] DFND 92,787 92,787
Millennium Management LLC [2025-06-30] SOLE 0 75,000
Laurion Capital Management LP [2025-06-30] SOLE 16,666 16,666
Vestcor Inc [2025-06-30] SOLE 9,632 9,632
CIBC Private Wealth Group LLC [2025-06-30] SOLE 3,000 3,000
Wolverine Asset Management LLC [2025-06-30] DFND 2,091 2,091
UBS Group AG [2025-06-30] DFND 993 993
Concourse Financial Group Securities Inc [2025-06-30] SOLE 0 0
Prev | Page 2 | Next
Terms | Privacy | Guide
tony@aum13f.com